GlassScriptPhysician profile
Melissa M Meyer
NPI 1760428049
$4,002.04
in general payments reported to CMS, 2019-2025
48 companies · $18.54 in 2025
The $18.54 reported for 2025 was less than what a typical Adult Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $924 · 2022: $1,880 · 2023: $1,032 · 2024: $147 · 2025: $18.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $352.19 | 2021-2023 | Imbruvica, Epkinly |
| Novartis Pharmaceuticals Corporation | $303.03 | 2021-2023 | |
| Amgen INC. | $290.80 | 2021-2023 | Lumakras, Kyprolis, Xgeva |
| Takeda Pharmaceuticals U.S.A., INC. | $238.02 | 2022-2023 | Alunbrig, Ninlaro |
| Janssen Biotech, INC. | $227.09 | 2021-2023 | Erleada |
| Daiichi Sankyo INC. | $187.28 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $181.67 | 2021-2023 | Keytruda |
| Genentech USA, INC. | $161.85 | 2021-2023 | Venclexta |
| Regeneron Healthcare Solutions, INC. | $156.48 | 2021-2023 | Libtayo |
| E.R. Squibb & Sons, L.L.C. | $150.19 | 2021-2024 | Opdivo, Camzyos |
| Lilly USA, LLC | $148.87 | 2021-2022 | |
| Incyte Corporation | $103.68 | 2022-2023 | Monjuvi, Pemazyre, Jakafi |
| Pfizer INC. | $98.71 | 2021-2023 | |
| Gilead Sciences, INC. | $93.81 | 2021-2023 | Trodelvy |
| Bayer Healthcare Pharmaceuticals INC. | $76.86 | 2022-2023 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.